UGN-102

UroGen submits new drug application to FDA for UGN-102
Pharmaceutical Business Review
Thu, 01/25/24 - 11:31 am
Urogen
FDA
UGN-102
urothelial cancer
Urogen's Potential First Non-Surgical Therapy for LG-IR-NMIBC Posts Promising Phase 3 Trial Data
Benzinga
Thu, 07/27/23 - 11:35 am
Urogen
clinical trials
UGN-102
non-muscle invasive bladder cancer
bladder cancer
UroGen reports data from Phase IIb trial of bladder cancer treatment
Clinical Trials Arena
Mon, 12/5/22 - 10:51 am
Urogen
clinical trials
UGN-102
bladder cancer